Novartis AG (NVS) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Novartis AG
Novartis AG is led by CEO Vasant Narasimhan, employs 75,883 people, headquartered in Basel, CH, publicly traded since 1996.
Novartis AG (NVS) stock trades at $143.11 with a market capitalization of $272.01B. The stock is valued at a price-to-earnings (P/E) ratio of 21.93, price-to-book of 6.61, price-to-sales of 5.01. Over the past 52 weeks the stock has ranged between $121.57 and $170.46, and currently trades 16.0% below its 52-week high. It pays a dividend yielding 3.26%.
On profitability, Novartis AG generates a return on equity (ROE) of 29.64% — well above the market average, a sign of a high-quality business, return on capital employed of 18.07%, an operating margin of 31.15%, a net profit margin of 23.09%.
In its most recent fiscal year, Novartis AG reported annual revenue of $54.8B, net profit of $14.1B, revenue has compounded at 1.9% a year over the last five years, profit at 11.7% a year. Profit growing faster than revenue points to expanding margins.
The balance sheet shows a debt-to-equity ratio of 1.18, a current ratio of 1.12, total assets of $115.6B, $11.4B in cash and equivalents.
NVS has a beta of 0.46 (less volatile than the overall market).